BioSpace News Archive

Biotech Bay

Jasper Therapeutics Announces Proposed Public Offering of Common Stock - Jan 24, 2023

Jasper Therapeutics, Inc. announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock in an underwritten public offering.

January 24, 2023
·
5 min read
Biotech Bay

Enable Medicine Identifies Sex-Dependent Differences in Resistance to Common Treatment for Ulcerative Colitis

Scientists from Enable Medicine, the infrastructure platform for biological data, published a new paper in Science Advances.

January 24, 2023
·
2 min read
Drug Development

Memo Therapeutics AG Announces Positive Phase I Data with AntiBKV for Treatment of BKV Infection in Renal Transplant Patients

Memo Therapeutics AG, an innovator in the field of antibody discovery and development, announced positive safety and tolerability data from a Phase I clinical trial with AntiBKV, an antibody targeting BK polyomavirus infection in renal transplant patients, meeting its primary endpoint.

January 24, 2023
·
3 min read
Nicox to Participate in Financial, Pharmaceutical Industry and Scientific Events in H1 2023

Nicox SA, an international ophthalmology company, that members of the management team will participate in the following financial, pharmaceutical industry and scientific conferences in Europe and U.S. in the coming months:.

January 24, 2023
·
3 min read
BioMidwest

CytoSMART Technologies Joins the Axion BioSystems Brand

Axion BioSystems, a leader in live-cell analysis tools, announced the full integration of imaging innovator CytoSMART Technologies into the Axion BioSystems brand.

January 24, 2023
·
1 min read
Business

Gandeeva Therapeutics Announces Appointment of Dr. Brenda G. Cooperstone to its Board of Directors

Gandeeva Therapeutics, Inc., a biotechnology company focused on designing and developing precision therapeutics guided by cryogenic electron microscopy and machine learning, announced the appointment of Brenda G. Cooperstone, MD, as an independent member of its Board of Directors.

January 24, 2023
·
2 min read
BioMidwest

Zomedica to Participate in the Lytham Partners Investor Select Conference

Zomedica Corp. announced today that the Company will be participating in the Lytham Partners Investor Select Conference taking place virtually on January 31, 2023.

January 24, 2023
·
1 min read
Deals

CymaBay Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants - January 24, 2023

CymaBay Therapeutics, Inc. today announced the pricing of its previously announced underwritten public offering of common stock and pre-funded warrants.

January 24, 2023
·
4 min read
TSE treatments at the Royal Veterinary College shows very promising results

Scandinavian ChemoTech’s fully owned subsidiary Vetiqure receives very promising updates from the veterinarians at the Royal Veterinary College, who will now continue to treat more patients.

January 24, 2023
·
3 min read
CollPlant Issues Letter to Shareholders - January 24, 2023

CollPlant is pleased to issue the following letter from its Chief Executive Officer, Yehiel Tal, to its shareholders.

January 24, 2023
·
13 min read